As Cvs Health Corp (CVS) Stock Value Declined, Holder Chilton Capital Management LLC Lowered Its Position by $5.36 Million

July 18, 2017 - By Ellis Scott

Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It fall, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Beacon Group reported 13,107 shares. De Burlo Gru Incorporated accumulated 20,755 shares or 0.4% of the stock. Finemark Bank &, a Florida-based fund reported 20,830 shares. Midwest Investment Mngmt Lc, a Ohio-based fund reported 20,872 shares. Mackenzie Fincl accumulated 0.35% or 729,988 shares. Davenport & Co Ltd holds 0.48% or 423,808 shares. 768,753 were accumulated by Victory Cap Mgmt Incorporated. Shell Asset has 102,265 shares. Charter reported 0.21% in CVS Health Corp (NYSE:CVS). Balasa Dinverno Foltz Lc reported 7,297 shares stake. 26,457 were reported by Clearline Cap Lp. Conning invested 0.16% of its portfolio in CVS Health Corp (NYSE:CVS). Thomas J Herzfeld Advsr holds 0.01% or 389 shares. Peak6 Investments LP reported 0.06% in CVS Health Corp (NYSE:CVS). Rosenbaum Jay D invested in 2.67% or 14,580 shares.

Since February 1, 2017, it had 0 insider buys, and 7 selling transactions for $40.53 million activity. Roberts Jonathan C had sold 61,196 shares worth $4.90M. $18.44 million worth of CVS Health Corp (NYSE:CVS) was sold by Denton David M on Monday, June 12. MERLO LARRY J had sold 76,494 shares worth $5.99 million on Wednesday, February 1. Boratto Eva C sold 6,029 shares worth $479,908. On Monday, March 13 the insider Sussman Andrew sold $1.13M. The insider Brennan Troyen A sold $1.88 million.

Chilton Capital Management Llc decreased its stake in Cvs Health Corp (CVS) by 39.31% based on its latest 2016Q4 regulatory filing with the SEC. Chilton Capital Management Llc sold 68,780 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 106,206 shares of the medical and nursing services company at the end of 2016Q4, valued at $8.38 million, down from 174,986 at the end of the previous reported quarter. Chilton Capital Management Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $80.15B market cap company. The stock increased 0.47% or $0.37 on July 17, reaching $78.3. About shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since July 18, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Analysts expect CVS Health Corp (NYSE:CVS) to report $1.31 EPS on August, 1.They anticipate $0.01 EPS change or 0.76 % from last quarter’s $1.32 EPS. CVS’s profit would be $1.34B giving it 14.94 P/E if the $1.31 EPS is correct. After having $1.17 EPS previously, CVS Health Corp’s analysts see 11.97 % EPS growth.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Fool.com which released: “How CVS Health Corporation Makes Most of Its Money” on June 30, 2017, also Zacks.com with their article: “CVS Health’s MinuteClinic Joins EOHN for Workplace Healthcare” published on July 12, 2017, Gurufocus.com published: “CVS Health and Valero Look Good by This Measure” on July 17, 2017. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Gurufocus.com and their article: “Narwhal Capital Management Buys Cigna Corp, TJX Inc, CVS Health Corp, Sells …” published on July 12, 2017 as well as Seekingalpha.com‘s news article titled: “CVS: Critical Reality Check” with publication date: July 06, 2017.

CVS Health Corp (NYSE:CVS) Ratings Coverage

Among 21 analysts covering CVS Health (NYSE:CVS), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. CVS Health has $132 highest and $77 lowest target. $107.59’s average target is 37.41% above currents $78.3 stock price. CVS Health had 32 analyst reports since July 22, 2015 according to SRatingsIntel. On Thursday, March 10 the stock rating was reinitiated by Barclays Capital with “Overweight”. On Monday, November 2 the stock rating was maintained by JP Morgan with “Overweight”. The firm earned “Hold” rating on Monday, December 12 by Jefferies. Morgan Stanley downgraded it to “Equal-Weight” rating and $104 target in Monday, June 20 report. On Wednesday, July 22 the stock rating was maintained by Deutsche Bank with “Hold”. The rating was initiated by Tigress Financial with “Buy” on Friday, April 28. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, August 5 report. The stock of CVS Health Corp (NYSE:CVS) earned “Hold” rating by Jefferies on Friday, June 9. The stock has “Buy” rating by Cowen & Co on Tuesday, June 13. Oppenheimer maintained CVS Health Corp (NYSE:CVS) on Monday, November 2 with “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.